Developed on: August 2020
Developed by: MRCT Center Diversity Workgroup
The MRCT Center Diversity Workgroup has developed a set of fundamental principles that help to frame considerations of diverse representation in clinical research. While we recognize that a case-based analysis will be required for each clinical research question, we also believe that these principles will help guide those analyses.
Developed on: August 2020
Developed by: MRCT Center Diversity Workgroup
There are practical and operational barriers that prevent routine participation of underrepresented, underserved, and diverse populations in clinical research. These must be addressed to promote change. While many challenges exist, for each section, we provide a key summary and recommendations to address appropriate representation in clinical research. Link to Resource >
Comments provided on: July 20, 2020
Comments provided to: Food and Drug Administration (FDA)
Comments provided on: June 29, 2020
Comments provided to: Food and Drug Administration (FDA)
Mark Barnes, MRCT Center Faculty Co-Director co-authored a special report in New England Journal of Medicine “Challenges of “Return to Work” in an Ongoing Pandemic.”
Presented on: June 18, 2020
Presented by: Barbara E. Bierer, MD
Presented at: DIA 2020 Virtual Global Annual Meeting
Presented on: June 18, 2020
Presented by: Sylvia Baedorf Kassis
Presented at: DIA 2020 Virtual Global Annual Meeting
In Science Magazine, MRCT Center Faculty Director Barbara Bierer along with her COVID-19 Collaboration Platform colleagues details the need for a home for clinical trial protocols that are available for collaboration.
“To increase the power of RCTs, we have created a pilot repository for RCT protocols led by principal investigators who are open to various levels of collaboration. On the COVID-19 Collaboration Platform (CovidCP.org), researchers can submit their draft or completed protocols and find collaborators.
Published on: January 20, 2020
Published in: Journal of Clinical Epidemiology
